This case underscores the importance of understanding PANDAS and its management. Despite multiple rounds of treatment including antibiotics, intravenous immunoglobulin treatment (IVIG), plasmapheresis, antipsychotics, mood stabilizers, antidepressants/anxiolytics, adenotonsillectomy, individual psychotherapy, and partial hospitalization programs, the patient’s condition remained resistant.

With more than 5,000 patients studied in clinical trials, Exxua has demonstrated effectiveness for relieving depressive symptoms with an acceptable side effect profile.

Did you know that recent court decisions could impact how we learn about drug risks? For instance, lecanemab (Leqembi), a new treatment for Alzheimer’s disease, has potential risks that are not fully disclosed in its label.

New research indicates that coffee can interact with certain medications including ephedrine, antidiabetic drugs, theophylline, and phenothiazines.

Recent studies have detected microplastics in human blood, placentas, heart tissue, and even the brain. As healthcare professionals, we must consider the potential implications of these findings on patient care and public health.

Did you know that medical gaslighting can have serious implications on the mental health and self-esteem of attendings, residents, and medical students? It’s time we address this issue in our healthcare system.